Review
Accepted on 03 May 2024
The Aryl Hydrocarbon Receptor (AhR) as a Tumor Modulator: Mechanisms to Therapy
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1375905
Type at least 3 characters
2,844 articles
Articles
Original Research
Published on 03 May 2024
Persistent gene expression and DNA methylation alterations linked to carcinogenic effects of dichloroacetic acid
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1389634
- 161 views
Original Research
Published on 02 May 2024
Phosphorylation of cell cycle and apoptosis regulatory protein-1 by stress activated protein kinase P38Îł is a novel mechanism of apoptosis signaling by genotoxic chemotherapy
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1376666
- 173 views
Original Research
Published on 02 May 2024
KDM7A-DT induces genotoxic stress, tumorigenesis, and progression of p53 missense mutation-associated invasive breast cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1227151
- 347 views
Review
Published on 30 Apr 2024
Research progress of cell membrane biomimetic nanoparticles for circulating tumor cells
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1389775
- 205 views
Review
Published on 30 Apr 2024
Exploring vasculogenesis in the normal human kidney and clear cell renal cell carcinoma: insights from development to tumor progression and biomarkers for therapy response
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1375190
- 228 views
Review
Published on 29 Apr 2024
Circular RNA PRKCI (hsa_circ_0067934): a potential target in the pathogenesis of human malignancies
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1365032
- 138 views
Review
Accepted on 26 Apr 2024
Biological Functions and Therapeutic Potential of SRY related high mobility group box 5 (SOX5) in human cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1332148
Review
Accepted on 25 Apr 2024
Fibrinogen and tumors
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1393599
Review
Published on 25 Apr 2024
Multiple functions of HMGB1 in cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1384109
- 206 views
Mini Review
Published on 25 Apr 2024
Metastatic organotropism: a brief overview
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1358786
- 223 views
Original Research
Published on 25 Apr 2024
Transcriptomic analysis and experiments revealed that remimazolam promotes proliferation and G1/S transition in HCT8 cells
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1345656
- 166 views
Editorial
Published on 23 Apr 2024
Editorial: Women in molecular and cellular oncology: 2023, volume III
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1413005
Mini Review
Accepted on 22 Apr 2024
P53/NANOG Balance; The leading Switch between Poorly to Well Differentiated Status in Liver Cancer Cells
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1377761
Review
Published on 22 Apr 2024
Circ_0003945: an emerging biomarker and therapeutic target for human diseases
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1275009
- 177 views
Original Research
Accepted on 19 Apr 2024
Age-Dependent Molecular Variations in Osteosarcoma: Implications for Precision Oncology Across Pediatric, Adolescent, and Adult Patients
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1382276